Compare Bio Protocol (BIO) vs MVL (MVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs MVL — how do they compare? Bio Protocol trades at Rp428.49 (market cap Rp974,32M, Rp148,57M 24h volume), while MVL trades at Rp16.38 (market cap Rp472,56M, Rp1,47M 24h volume). The key difference: Bio Protocol is far larger — about 2.1× MVL's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 27,8B / 30B MVL (93%) for MVL. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and MVL for 58 Days on average.
| BIO | MVL | |
|---|---|---|
Market Cap | Rp974,32M | Rp472,56M |
Volume (24h) | Rp148,57M | Rp1,47M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 27,8B / 30B MVL (93%) |
Typical Hold Time | 18 Days | 58 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
MVL is a cryptocurrency with a market cap of Rp472,56M and a circulating supply of 27,8M tokens out of a 30M max supply, indicating 93% circulation. The average hold time is 58 days. Current price data is unavailable for technical analysis. No recent protocol updates or ecosystem news were identified, suggesting a period of stability or low development activity.
The outlook is neutral with low liquidity as a primary risk. The main opportunity lies in the high circulation rate, which may reduce inflationary sell pressure. Major risks include market volatility due to low trading volume and the absence of recent fundamental developments to drive value.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About MVL
MVL, which stands for Mobility Value Lab, is an innovative project that combines the fields of mobility and blockchain technology. The primary goal of MVL is to share data value among all participants in its ecosystem. This integration is accomplished using various blockchain protocols that are designed to enhance the development of mobility services.
Read more on MVL →
